日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Short-Term Efficacy and Safety of Haizao Yuhu Decoction Plus Methimazole versus Methimazole Monotherapy for Graves' Disease: A Prospective Study Using Propensity Score-Matching

海藻玉虎汤联合甲巯咪唑与甲巯咪唑单药治疗格雷夫斯病短期疗效及安全性比较：一项采用倾向评分匹配的前瞻性研究

期刊:International Journal of General Medicine
影响因子:2
doi:10.2147/IJGM.S593965
Huang, Wenbin; Cheng, Fengyun; Liu, Xiaoju; Li, Xingjia; Zhou, Sicong; Lin, Rong; Zhu, Fenxia; Mao, Xiaodong; Liu, Chao; Xu, Shuhang
发表日期：2026
文献求助 收藏

Elucidating the pharmacological foundations and mechanisms of the Sihai Shuyu formula in treating Graves' disease through integrated serum metabolomics and network pharmacology with molecular docking techniques.

通过整合血清代谢组学和网络药理学以及分子对接技术，阐明四海舒郁方治疗格雷夫斯病的药理学基础和机制

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1511808
Liu Xiaoju, Li Xingjia, Huang Wenbin, Cui Yifan, Cheng Fengyun, Chen Guofang, Mao Xiaodong, Liu Chao, Xu Shuhang
代谢
发表日期：2025
文献求助 收藏

ZNF191 alters DNA methylation and activates the PI3K-AKT pathway in hepatoma cells via transcriptional regulation of DNMT1

ZNF191 通过转录调控 DNMT1 改变 DNA 甲基化并激活肝癌细胞中的 PI3K-AKT 通路

期刊:Cancer Medicine
影响因子:2.9
doi:10.1002/cam4.4535
Yufeng Liu, Hanghang Cheng, Chenchen Cheng, Fengyun Zheng, Zhonghua Zhao, Qi Chen, Wenjiao Zeng, Pingzhao Zhang, Cheng Huang, Wei Jiang, Xiuping Liu, Guoyuan Liu
信号转导
肿瘤
表观遗传
肝癌
肿瘤细胞
DNA甲基化
Epigenetics
PI3K/Akt
发表日期：2022
文献求助 收藏